SYK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Stryker Corp (SYK) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company demonstrates strong financial performance and positive long-term growth prospects, the lack of immediate positive trading signals, bearish technical indicators, and hedge fund selling trends suggest holding off on investing right now.
The stock's technical indicators are mixed to bearish. The MACD histogram is positive but contracting, suggesting weakening bullish momentum. RSI is neutral at 35.544, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 327.904, with resistance at 338.562. These signals do not indicate a strong buy opportunity.
Strong financial performance in Q4 2025, with revenue up 11.42% YoY and net income up 55.49% YoY.
Analysts highlight Stryker's high-quality growth and diversified product portfolio, with potential for sustained outsized growth.
Positive long-term growth prospects in higher-growth end markets.
Hedge funds are selling, with a 119.77% increase in selling activity last quarter.
Bearish technical indicators and lack of immediate trading signals.
Analysts have recently lowered price targets, citing cautious sentiment around Q1 results and potential cybersecurity risks.
In Q4 2025, Stryker's revenue increased to $7.171 billion, up 11.42% YoY. Net income rose to $849 million, a 55.49% YoY increase, and EPS grew by 56.03% YoY to 2.2. However, gross margin slightly declined to 62.61%, down -0.46% YoY.
Analyst sentiment is mixed. While some firms maintain Buy or Outperform ratings, others have reduced price targets due to cautious sentiment around Q1 results and cybersecurity risks. Price targets range from $365 to $410, with a general consensus of high-quality growth but near-term uncertainties.
